Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 24 (KRT24) is a type I intermediate filament protein expressed predominantly in differentiated epithelial tissues, especially the suprabasal layer of the corneal epithelium, with lower levels in epidermis and other squamous epithelia[3]. It plays a role in keratinocyte terminal differentiation, inhibition of cell cycle progression at G1/S, induction of senescence, autophagy, and apoptosis, and suppression of cell migration, possibly through PKCδ signaling[1]. KRT24 is not essential for cytoskeletal formation, but it likely contributes to the specialized properties of differentiated epithelial cells. It may serve as a marker of aging, differentiation, and has potential as a biomarker for certain skin and corneal conditions, but is not recognized as a therapeutic target or receptor at present[1][3].
Not applicable, as there are no known drugs targeting KRT24. Mechanistic studies show it functions through the PKCδ signaling pathway affecting cell cycle arrest, apoptosis, and differentiation[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin, type I cytoskeletal 24 (KRT24).